Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001047469-08-002920
Filing Date
2008-03-17
Accepted
2008-03-17 15:16:58
Documents
11
Period of Report
2007-12-31

Document Format Files

Seq Description Document Type Size
1 10-K a2183632z10-k.htm 10-K 1006551
2 EXHIBIT 10.47 a2183632zex-10_47.htm EX-10.47 1213438
3 EXHIBIT 10.54 a2183632zex-10_54.htm EX-10.54 75207
4 EXHIBIT 21.1 a2183632zex-21_1.htm EX-21.1 3417
5 EXHIBIT 23.1 a2183632zex-23_1.htm EX-23.1 3373
6 EXHIBIT 31.1 a2183632zex-31_1.htm EX-31.1 11404
7 EXHIBIT 31.2 a2183632zex-31_2.htm EX-31.2 11766
8 EXHIBIT 32.1 a2183632zex-32_1.htm EX-32.1 6248
9 EXHIBIT 32.2 a2183632zex-32_2.htm EX-32.2 6791
10 G579979.JPG g579979.jpg GRAPHIC 46041
11 G348115.JPG g348115.jpg GRAPHIC 18399
  Complete submission text file 0001047469-08-002920.txt   2428760
Mailing Address 341 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address 341 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080 650-266-3500
SUNESIS PHARMACEUTICALS INC (Filer) CIK: 0001061027 (see all company filings)

EIN.: 943295878 | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-51531 | Film No.: 08692623
SIC: 2834 Pharmaceutical Preparations